Skip to main content

Medical Product Supply Updates

The Therapeutic Goods Administration (TGA) publishes information about medical product shortages on its website 

A medicine shortage occurs when there is unlikely to be enough of a medicine in Australia for the people who need to take it. Suppliers must report shortages of prescription medicines and a small number of over-the-counter medicines to the TGA. Each shortage listed on the TGA medicine shortages reports page refers to a single product. There are usually alternative brands, strengths or dose forms of the same medicine available. 

Product Availability – Recent Updates 2023-2024

Respiratory Syncytial Virus (RSV) vaccine approved by TGA

Monovalent COVID-19 Omicron XBB.1.5 vaccines

Shingrix® varicella zoster virus recombinant vaccine

Jorveza® for the treatment of eosinophilic oesophagitis (EoE)

Dymista® Allergy nasal spray for treatment of allergic rhinitis – now OTC

Content updated January 2024